[1]李瑞林,苏 阳,雷丽霞,等.中医外治法治疗恶性肿瘤胸腹腔积液研究现状[J].医学信息,2022,35(24):183-185.[doi:10.3969/j.issn.1006-1959.2022.24.041]
　LI Rui-lin,SU Yang,LEI Li-xia,et al.Research Status of External Treatment of Traditional Chinese Medicine in the Treatment of Malignant Tumor Pleural Effusion[J].Journal of Medical Information,2022,35(24):183-185.[doi:10.3969/j.issn.1006-1959.2022.24.041]
点击复制

中医外治法治疗恶性肿瘤胸腹腔积液研究现状()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年24期
页码:
183-185
栏目:
综述
出版日期:
2022-12-15

文章信息/Info

Title:
Research Status of External Treatment of Traditional Chinese Medicine in the Treatment of Malignant Tumor Pleural Effusion
文章编号:
1006-1959（2022）24-0183-03
作者:
李瑞林; 苏 阳; 雷丽霞; 等
（1.新疆医科大学中医学院，新疆 乌鲁木齐 830000；2.新疆医科大学第四临床医学院，新疆 乌鲁木齐 830000；3.新疆昌吉州中医医院肿瘤内科，新疆 昌吉 831100）
Author(s):
LI Rui-lin; SU Yang; LEI Li-xia; et al.
(1.College of Traditional Chinese Medicine,Xinjiang Medical University,Urumqi 830000,Xinjiang,China;2.The Fourth Clinical Medical College of Xinjiang Medical University,Urumqi 830000,Xinjiang,China;3.Department of Oncology,Xinjiang Changji Hospital of T
关键词:
恶性肿瘤; 胸腹腔积液; 中医外治法
Keywords:
Malignant tumor; Pleural effusion; External treatment of traditional Chinese medicine
分类号:
R730.53；R273
DOI:
10.3969/j.issn.1006-1959.2022.24.041
文献标志码:
A
摘要:
恶性肿瘤胸腹腔积液是中晚期癌症患者常见并发症，其发生率较高，严重影响患者的生活质量和生存周期。中医外治法是中医药特色治疗方法之一，在肿瘤的治疗与调护方面具有较好的作用，不仅可以起到减毒增效的作用，还可以提高患者生活质量、阻止病情进展，在治疗恶性肿瘤并发症方面有着一定的作用，尤其在治疗胸腹腔积液方面效果良好。本文主要对中医外治法治疗恶性肿瘤胸腹腔积液的研究现状进行综述，以期为临床治疗恶性肿瘤胸腹腔积液提供参考。
Abstract:
Malignant tumor pleural effusion is a common complication in patients with advanced cancer, and its incidence is high, which seriously affects the quality of life and life cycle of patients. External treatment of traditional Chinese medicine is one of the characteristic treatment methods of traditional Chinese medicine. It has a good effect in the treatment and nursing of tumors. It can not only reduce toxicity and increase efficiency, but also improve the quality of life of patients and prevent the progression of the disease. It has a certain effect in the treatment of malignant tumor complications, especially in the treatment of pleural effusion. This article mainly reviews the research status of traditional Chinese medicine external treatment for malignant tumor pleural effusion, in order to provide reference for clinical treatment of malignant tumor pleural effusion.

参考文献/References:

[1]秦叔逵,李进,韩宝惠,等.重组人血管内皮抑制素治疗恶性浆膜腔积液临床应用专家共识[J].临床肿瘤学杂志,2020,25(9):849-856.[2]王帅,刘素艳,李艳艳,等.榄香烯联合奈达铂治疗恶性胸腹水临床观察[J].中华肿瘤防治杂志,2018,25(18):1328-1331.[3]Bashour SI,Mankidy BJ,Lazarus DR.Update on the diagnosis and management of malignant pleural effusions[J].Respiratory Medicine,2022,196:106802.[4]李栋,姜子瑜,张培影,等.重组改构人肿瘤坏死因子经胸腔注射治疗恶性胸腔积液41例临床疗效研究[J].肿瘤药学,2016,6(6):456-460.[5]高丽萍,程俊,孟令占,等.重组改构人肿瘤坏死因子姑息治疗晚期肿瘤伴随恶性胸腔积液的临床观察[J].癌症进展,2016,14(7):678-680.[6]中国恶性胸腔积液诊断与治疗专家共识组.恶性胸腔积液诊断与治疗专家共识[J].中华内科杂志,2014,53(3):252-256.[7]凡伟林.热疗联合腔内灌注化疗治疗恶性胸腹腔积液的效果[J].临床合理用药杂志,2021,14(34):169-171.[8]程晓云,肖敬,张淑平.高频热疗并顺铂腔内化疗治疗恶性胸腔积液疗效分析[J].现代肿瘤医学,2020,28(21):3715-3718.[9]刘丽萍,常青,杜林燕,等.阿帕替尼联合热灌注化疗治疗恶性腹腔积液[J].深圳中西医结合杂志,2020,30(14):106-107.[10]李小勤,黄春梅,罗娟,等.信迪利单抗联合AP化疗治疗晚期肺腺癌合并恶性胸腔积液的临床研究[J].河北医学,2021,27(12):2079-2084.[11]秦叔逵,杨柳青,梁军,等.腔内应用重组人血管内皮抑制素和/或顺铂治疗恶性胸腹腔积液的前瞻性、随机对照、全国多中心Ⅲ期临床研究[J].临床肿瘤学杂志,2017,22(3):193-202.[12]刘勇.化疗联合免疫治疗恶性胸腔积液的临床疗效及其对患者免疫功能的影响[J].临床合理用药杂志,2018,11(18):64-66.[13]张莹,贾英杰,李小江,等.榄香烯注射液联合热疗治疗中度恶性胸腔积液临床观察[J].天津中医药,2018,35(5):340-343.[14]罗玉妍,孙雅君,张玲燕.甘遂半夏汤加减外敷联合紫杉醇胸腔灌注治疗恶性肿瘤胸腔积液临床疗效观察[J].中西医结合心血管病电子杂志,2019,7(26):139,141.[15]王霞,姜润学.贝伐珠单抗联合腹腔热灌注化疗治疗胃癌伴恶性腹腔积液效果观察[J].肿瘤研究与临床,2020,32(10):701-704.[16]Bashour SI,Mankidy BJ,Lazarus DR.Update on the diagnosis and management of malignant pleural effusions[J].Respir Med,2022,196:106802.[17]樊柄杰,周彤,李铮,等.基于“病痰饮者，当以温药和之”探讨恶性胸腔积液治疗思路[J].湖南中医药大学学报,2021,41(11):1756-1760.[18]袁菊花,贾立群,吴煜,等.恶性腹水从“阳”论治[J].中医学报,2019,34(9):1829-1832.[19]于秀荣,李慧杰,齐元富.中医外治法在肿瘤常见并发症及放化疗毒副反应中的应用[J].山东中医杂志,2019,38(2):193-196.[20]王幸.中药外用治疗恶性胸腹腔积液的临床观察[D].北京:北京中医药大学,2010.[21]刘猛,贾立群,李仝,等.抗癌消水膏外治恶性胸腹腔积液59例的临床观察[J].中国中西医结合杂志,2018,38(4):498-500.[22]王佛有,李戈.实脾消水散穴位贴敷联合西药治疗恶性腹腔积液20例临床观察[J].实用中医内科杂志,2019,33(2):45-47.[23]蔡亚红,洪佳娜,林娟英.“温阳逐水方”脐疗联合艾盐包热熨治疗癌性腹水的疗效观察[J].浙江中医药大学学报,2017,41(5):416-417,424.[24]李睿,罗梓桓.针灸联合中药治疗卵巢癌恶性腹腔积液临床观察[J].上海针灸杂志,2020,39(8):1017-1021.[25]刘丹,姚军,邓海燕.利水膏联合艾灸治疗大肠癌晚期恶性腹腔积液[J].中医学报,2018,33(7):1179-1181.[26]周丽.复方苦参注射液联合卡铂腹腔灌注治疗恶性腹腔积液临床研究[J].辽宁中医杂志,2022,49(2):131-132.[27]贺娟娟,李延玲,郭瑞霞,等.复方苦参注射液联合TP方案治疗晚期肺癌恶性胸腔积液疗效及对CEA、AFP和NSE水平的影响[J].现代中西医结合杂志,2020,29(33):3670-3673,3678.[28]王一同,周琴,郑俊超,等.华蟾素注射液灌注治疗恶性血性胸腹腔积液的疗效评价及优势人群研究[J]. 现代中西医结合杂志,2020,29(30):3313-3317,3326.[29]卢立欣,刘学红.腹腔灌注化疗药物联合薏苡仁油注射液治疗恶性腹腔积液的临床效果观察[J].实用癌症杂志,2018,33(11):1819-1822.

相似文献/References:

[1]袁东方,张刚刚.恶性肿瘤病历主要诊断选择思路分析[J].医学信息,2018,31(07):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
　YUAN Dong-fang,ZHANG Gang-gang.Analysis of Main Diagnostic Options for Malignant Tumor Records[J].Journal of Medical Information,2018,31(24):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
[2]陶碧君,刘建德,王玉洲.LncRNA FOXD3-AS1在恶性肿瘤中的表达、功能及作用机制[J].医学信息,2022,35(10):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
　TAO Bi-jun,LIU Jian-de,WANG Yu-zhou.Expression, Function and Mechanism of LncRNA FOXD3-AS1 in Malignant Tumors[J].Journal of Medical Information,2022,35(24):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
[3]张国锐,贾 林,赵 丹,等.老年维持血液透析患者恶性肿瘤发病的相关因素分析[J].医学信息,2022,35(10):113.[doi:10.3969/j.issn.1006-1959.2022.10.027]
　ZHANG Guo-rui,JIA Lin,ZHAO Dan,et al.Analysis of Related Factors of Malignant Tumor in Elderly Maintenance Hemodialysis Patients[J].Journal of Medical Information,2022,35(24):113.[doi:10.3969/j.issn.1006-1959.2022.10.027]
[4]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
　JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Journal of Medical Information,2019,32(24):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
[5]何 静.上皮性卵巢癌化学治疗的研究[J].医学信息,2019,32(18):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
　HE Jing.Chemotherapy of Epithelial Ovarian Cancer[J].Journal of Medical Information,2019,32(24):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
[6]梁春玲,杨文珊.消化道恶性肿瘤的临床分析[J].医学信息,2019,32(18):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
　LIANG Chun-ling,YANG Wen-shan.Clinical Analysis of Malignant Tumors of the Digestive Tract[J].Journal of Medical Information,2019,32(24):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
[7]陈云娥,李 璠,张子怡,等.营养支持治疗对终末期恶性肿瘤患者临床结局影响的Meta分析[J].医学信息,2019,32(19):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
　CHEN Yun-e,LI Fan,ZHANG Zi-yi,et al.Meta-analysis of Effect of Nutritional Support Therapy on Clinical Outcome of Patients with Terminal-stage Malignant Tumor[J].Journal of Medical Information,2019,32(24):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
[8]杜鑫荣.超声造影在肝实质性肿块诊断及鉴别中的临床价值[J].医学信息,2019,32(19):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
　DU Xin-rong.Clinical Value of Contrast-enhanced Ultrasonography in the Diagnosis and Differential Diagnosis of Liver Mass[J].Journal of Medical Information,2019,32(24):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
[9]易亭伍,邓窈窕,宿向东.恶性肿瘤患者及家属信息需求现状的多中心研究[J].医学信息,2019,32(22):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
　YI Ting-wu,DENG Yao-tiao,SU Xiang-dong.Multi-center Study on the Status of Information Needs of Patients with Malignant Tumors and their Families[J].Journal of Medical Information,2019,32(24):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
[10]赵博志,赵国林,杨 敏,等.乳腺鳞状细胞癌的临床诊疗研究[J].医学信息,2020,33(03):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
　ZHAO Bo-zhi,ZHAO Guo-lin,YANG Min,et al.Clinical Diagnosis and Treatment of Squamous Cell Carcinoma of the Breast[J].Journal of Medical Information,2020,33(24):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]

更新日期/Last Update: 1900-01-01